State Street SPDR SandP Biotech ETF (XBI) |
| 151.4 -2.37 (-1.54%) 10-12 16:00 |
| Open: | 153.62 |
| High: | 154.15 |
| Low: | 151.1 |
| Volume: | 6,044,693 |
| Market Cap: | 7,916(M) |
| PE Ratio: | 20.63 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 163.43 |
| Resistance 1: | 156.78 |
| Pivot price: | 154.66 |
| Support 1: | 146.01 |
| Support 2: | 121.48 |
| 52w High: | 169.89 |
| 52w Low: | 103.43 |
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Mon, 12 Oct 2026
Biotech’s Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism - ETF Database
Sun, 11 Oct 2026
How to Buy State Street SPDR S&P Biotech ETF (Derivatives) (XBI) in Fiji with Credit Card Online - Bitget
Sat, 10 Oct 2026
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - Yahoo Finance
Mon, 05 Oct 2026
Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotech - The Motley Fool
Sun, 04 Oct 2026
Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals - The Globe and Mail
Sun, 04 Oct 2026
Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals - The Motley Fool
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |